Bright teams have run trials in nearly every therapeutic area — including the ones most CROs decline. We bring real clinical fluency, not just process.
Solid tumors, hematology, biomarker-driven trials, companion diagnostics.
Reproductive health, menopause, gynecologic indications, maternal-fetal.
Prophylactic and therapeutic vaccine programs across phases.
Heart failure, lipid disorders, anti-thrombotics, hypertension.
Neurodegenerative disease, psychiatry, pain, neurodevelopmental.
Rheumatology, dermatology, gastroenterology indications.
Antivirals, antibacterials, anti-fungals, global health.
Diabetes, thyroid, metabolic, rare endocrine disorders.
Topicals, biologics, aesthetic and medical dermatology.
Anterior and posterior segment, device-drug combos.
Asthma, COPD, IPF, inhalation device programs.
Age-appropriate study design, family-centered protocols.
Critical care, healthy volunteers, ethnic-specific cohorts.
510(k), PMA, IDE — combination products and SaMD.